+データを開く
-基本情報
登録情報 | データベース: PDB / ID: 6l37 | ||||||
---|---|---|---|---|---|---|---|
タイトル | X-ray structure of human PPARalpha ligand binding domain-GW9662-ciprofibrate co-crystals obtained by delipidation and co-crystallization | ||||||
要素 | Peroxisome proliferator-activated receptor alpha | ||||||
キーワード | TRANSCRIPTION / Nuclear receptor / Protein-ligand complex / PPAR | ||||||
機能・相同性 | 機能・相同性情報 positive regulation of transformation of host cell by virus / regulation of fatty acid transport / enamel mineralization / negative regulation of cell growth involved in cardiac muscle cell development / lipoprotein metabolic process / regulation of fatty acid metabolic process / positive regulation of fatty acid oxidation / cellular response to fructose stimulus / regulation of ketone metabolic process / behavioral response to nicotine ...positive regulation of transformation of host cell by virus / regulation of fatty acid transport / enamel mineralization / negative regulation of cell growth involved in cardiac muscle cell development / lipoprotein metabolic process / regulation of fatty acid metabolic process / positive regulation of fatty acid oxidation / cellular response to fructose stimulus / regulation of ketone metabolic process / behavioral response to nicotine / negative regulation of appetite / positive regulation of fatty acid beta-oxidation / negative regulation of hepatocyte apoptotic process / mitogen-activated protein kinase kinase kinase binding / negative regulation of leukocyte cell-cell adhesion / ubiquitin conjugating enzyme binding / negative regulation of glycolytic process / negative regulation of sequestering of triglyceride / nuclear steroid receptor activity / DNA-binding transcription activator activity / nitric oxide metabolic process / positive regulation of fatty acid metabolic process / NFAT protein binding / positive regulation of ATP biosynthetic process / negative regulation of cholesterol storage / negative regulation of macrophage derived foam cell differentiation / negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction / negative regulation of cytokine production involved in inflammatory response / epidermis development / phosphatase binding / positive regulation of lipid biosynthetic process / Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 / negative regulation of reactive oxygen species biosynthetic process / positive regulation of gluconeogenesis / negative regulation of signaling receptor activity / MDM2/MDM4 family protein binding / RORA activates gene expression / negative regulation of blood pressure / Regulation of lipid metabolism by PPARalpha / hormone-mediated signaling pathway / cellular response to starvation / response to nutrient / BMAL1:CLOCK,NPAS2 activates circadian gene expression / negative regulation of miRNA transcription / Activation of gene expression by SREBF (SREBP) / gluconeogenesis / fatty acid metabolic process / negative regulation of transforming growth factor beta receptor signaling pathway / circadian regulation of gene expression / wound healing / SUMOylation of intracellular receptors / Heme signaling / response to insulin / regulation of circadian rhythm / Transcriptional activation of mitochondrial biogenesis / PPARA activates gene expression / Cytoprotection by HMOX1 / DNA-binding transcription repressor activity, RNA polymerase II-specific / transcription coactivator binding / negative regulation of inflammatory response / Transcriptional regulation of white adipocyte differentiation / Nuclear Receptor transcription pathway / nuclear receptor activity / Circadian Clock / heart development / DNA-binding transcription activator activity, RNA polymerase II-specific / DNA-binding transcription factor binding / response to ethanol / RNA polymerase II-specific DNA-binding transcription factor binding / sequence-specific DNA binding / cell differentiation / response to hypoxia / DNA-binding transcription factor activity, RNA polymerase II-specific / DNA-binding transcription factor activity / RNA polymerase II cis-regulatory region sequence-specific DNA binding / protein domain specific binding / lipid binding / protein-containing complex binding / chromatin / positive regulation of DNA-templated transcription / negative regulation of transcription by RNA polymerase II / positive regulation of transcription by RNA polymerase II / DNA binding / zinc ion binding / nucleoplasm / nucleus 類似検索 - 分子機能 | ||||||
生物種 | Homo sapiens (ヒト) | ||||||
手法 | X線回折 / シンクロトロン / 分子置換 / 解像度: 2.91 Å | ||||||
データ登録者 | Kamata, S. / Saito, K. / Honda, A. / Ishikawa, R. / Oyama, T. / Ishii, I. | ||||||
資金援助 | 日本, 1件
| ||||||
引用 | ジャーナル: Iscience / 年: 2020 タイトル: PPAR alpha Ligand-Binding Domain Structures with Endogenous Fatty Acids and Fibrates. 著者: Kamata, S. / Oyama, T. / Saito, K. / Honda, A. / Yamamoto, Y. / Suda, K. / Ishikawa, R. / Itoh, T. / Watanabe, Y. / Shibata, T. / Uchida, K. / Suematsu, M. / Ishii, I. | ||||||
履歴 |
|
-構造の表示
構造ビューア | 分子: MolmilJmol/JSmol |
---|
-ダウンロードとリンク
-ダウンロード
PDBx/mmCIF形式 | 6l37.cif.gz | 125.3 KB | 表示 | PDBx/mmCIF形式 |
---|---|---|---|---|
PDB形式 | pdb6l37.ent.gz | 96.5 KB | 表示 | PDB形式 |
PDBx/mmJSON形式 | 6l37.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
その他 | その他のダウンロード |
-検証レポート
文書・要旨 | 6l37_validation.pdf.gz | 2.3 MB | 表示 | wwPDB検証レポート |
---|---|---|---|---|
文書・詳細版 | 6l37_full_validation.pdf.gz | 2.3 MB | 表示 | |
XML形式データ | 6l37_validation.xml.gz | 23.4 KB | 表示 | |
CIF形式データ | 6l37_validation.cif.gz | 30.3 KB | 表示 | |
アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/l3/6l37 ftp://data.pdbj.org/pub/pdb/validation_reports/l3/6l37 | HTTPS FTP |
-関連構造データ
関連構造データ | 6kaxC 6kayC 6kazC 6kb0C 6kb1C 6kb2C 6kb3C 6kb4C 6kb5C 6kb6C 6kb7C 6kb8C 6kb9C 6kbaC 6kypC 6l36C 6l38C 6lx4C 6lx5C 6lx6C 6lx7C 6lx8C 6lx9C 6lxaC 6lxbC 6lxcC 7bpyC 7bpzC 7bq0C 7bq1C 7bq2C 7bq3C 7bq4C 3vi8S S: 精密化の開始モデル C: 同じ文献を引用 (文献) |
---|---|
類似構造データ |
-リンク
-集合体
登録構造単位 |
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||||||
2 |
| ||||||||||||
単位格子 |
|
-要素
#1: タンパク質 | 分子量: 30856.053 Da / 分子数: 2 / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / プラスミド: pET28a / 発現宿主: Escherichia coli (大腸菌) / 参照: UniProt: Q07869 #2: 化合物 | ChemComp-GW9 / #3: 化合物 | 研究の焦点であるリガンドがあるか | Y | Has protein modification | Y | |
---|
-実験情報
-実験
実験 | 手法: X線回折 / 使用した結晶の数: 1 |
---|
-試料調製
結晶 | マシュー密度: 3.07 Å3/Da / 溶媒含有率: 59.89 % |
---|---|
結晶化 | 温度: 277 K / 手法: 蒸気拡散法 / 詳細: 0.1 M Tris (pH 8.0), 25 %(w/v) PEG3350 |
-データ収集
回折 | 平均測定温度: 100 K / Serial crystal experiment: N |
---|---|
放射光源 | 由来: シンクロトロン / サイト: Photon Factory / ビームライン: BL-17A / 波長: 1 Å |
検出器 | タイプ: DECTRIS PILATUS3 S 6M / 検出器: PIXEL / 日付: 2019年2月23日 / 詳細: Mirrors |
放射 | モノクロメーター: Si(111) / プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 1 Å / 相対比: 1 |
反射 | 解像度: 2.91→47 Å / Num. obs: 16226 / % possible obs: 99.1 % / 冗長度: 3.5 % / CC1/2: 1 / Rmerge(I) obs: 0.031 / Rpim(I) all: 0.02 / Rrim(I) all: 0.037 / Net I/σ(I): 23.7 |
反射 シェル | 解像度: 2.91→3.09 Å / 冗長度: 3.5 % / Rmerge(I) obs: 0.285 / Mean I/σ(I) obs: 4.2 / Num. unique obs: 2616 / CC1/2: 0.94 / Rpim(I) all: 0.177 / Rrim(I) all: 0.336 / % possible all: 99.4 |
-解析
ソフトウェア |
| ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: 分子置換 開始モデル: 3VI8 解像度: 2.91→36.482 Å / SU ML: 0.48 / 交差検証法: FREE R-VALUE / σ(F): 1.92 / 位相誤差: 28.9 詳細: SF FILE CONTAINS FRIEDEL PAIRS UNDER I/F_MINUS AND I/F_PLUS COLUMNS.
| ||||||||||||||||
溶媒の処理 | 減衰半径: 0.9 Å / VDWプローブ半径: 1.11 Å | ||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 2.91→36.482 Å
| ||||||||||||||||
LS精密化 シェル | 解像度: 2.91→3.0039 Å
|